TMC-256A1 and C1, new inhibitors of IL-4 signal transduction produced by Aspergillus niger var niger TC 1629

J Antibiot (Tokyo). 2002 Aug;55(8):685-92. doi: 10.7164/antibiotics.55.685.

Abstract

New inhibitors of IL-4 signal transduction, designated as TMC-256A1 and C1, were discovered together with TMC-256B1, a previously known dihydronaphthopyrone, from the fermentation broth of Aspergillus niger var niger TC 1629 by using an IL-4 driven reporter gene assay. Based on spectroscopic analyses, TMC-256A1 and C1 were found to be new members of the naphthopyrone antibiotics. TMC-256A1, B1 and C1 inhibited the IL-4 driven luciferase activity with IC50 values of 25 microM, 30 microM and 1.7 microM, respectively in this assay system. Furthermore, these compounds inhibited the expression of germline C epsilon mRNA with IC50 values of 6.6 microM , 34 microM and 0.31 microM, respectively.

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology*
  • Aspergillus niger / classification
  • Aspergillus niger / metabolism*
  • B-Lymphocytes / immunology
  • Chromones / chemistry
  • Chromones / metabolism*
  • Chromones / pharmacology
  • HeLa Cells
  • Humans
  • Immunoglobulin E / metabolism
  • Interferon-gamma / pharmacology
  • Interleukin-4 / antagonists & inhibitors*
  • Interleukin-4 / pharmacology
  • Luciferases / genetics
  • Luciferases / metabolism
  • Lymphocyte Activation
  • Magnetic Resonance Spectroscopy
  • Naphthalenes / chemistry
  • Naphthalenes / metabolism
  • Naphthalenes / pharmacology*
  • Pyrones / chemistry
  • Pyrones / metabolism
  • Pyrones / pharmacology*
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Signal Transduction / drug effects*
  • Transfection
  • Tumor Cells, Cultured

Substances

  • Anti-Bacterial Agents
  • Chromones
  • Naphthalenes
  • Pyrones
  • RNA, Messenger
  • TMC 256A1
  • TMC 256C1
  • Interleukin-4
  • Immunoglobulin E
  • Interferon-gamma
  • Luciferases